RADIOPHARM THERANOSTICS - RAD101 SHOWS PRELIMINARY 86% SENSITIVITY IN SIX-MONTH FOLLOW-UP; SPECIFICITY DATA EXPECTED Q4 2026

Reuters · 3d ago

Please log in to view news